Fadi N Salloum
Overview
Explore the profile of Fadi N Salloum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
3767
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu X, Li L, Nkwocha J, Kmieciak M, Shang S, Cowart L, et al.
Signal Transduct Target Ther
. 2025 Feb;
10(1):50.
PMID: 39924517
The importance of MCL-1 in leukemogenesis has prompted development of MCL-1 antagonists e.g., S63845, MIK665. However, their effectiveness in acute myeloid leukemia (AML) is limited by compensatory MCL-1 accumulation via...
2.
Alebna P, Han C, Ambrosio M, Kong G, Cyrus J, Harley K, et al.
JACC Adv
. 2024 Dec;
3(12):101409.
PMID: 39640230
Background: Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease. The relationship between Lp(a) and major adverse cardiovascular events (MACE) in the context of high-sensitivity C-reactive protein (hs-CRP)...
3.
Kovilakath A, Mauro A, Valentine Y, Raucci F, Jamil M, Carter C, et al.
Circulation
. 2024 Apr;
150(8):622-641.
PMID: 38660786
Background: Dysregulated metabolism of bioactive sphingolipids, including ceramides and sphingosine-1-phosphate, has been implicated in cardiovascular disease, although the specific species, disease contexts, and cellular roles are not completely understood. Sphingolipids...
4.
Garg R, DAgostino Jr R, OConnell N, Lesser G, Salloum F, Hines A, et al.
Hypertension
. 2024 Apr;
81(6):1365-1373.
PMID: 38634292
Background: Hypertension is a risk factor for experiencing left ventricular ejection fraction (LVEF) declines during receipt of potentially cardiotoxic breast cancer (BC) treatment. We sought to determine whether the hypertension...
5.
Salloum F, Tocchetti C, Ameri P, Ardehali H, Asnani A, de Boer R, et al.
JACC CardioOncol
. 2024 Jan;
5(6):715-731.
PMID: 38205010
Despite improvements in cancer survival, cancer therapy-related cardiovascular toxicity has risen to become a prominent clinical challenge. This has led to the growth of the burgeoning field of cardio-oncology, which...
6.
Jain V, Mehta A, Lee T, Liu C, Chew N, Ko Y, et al.
J Am Heart Assoc
. 2023 Dec;
12(24):e031230.
PMID: 38063161
Background: Literature suggests a bidirectional association between advanced hepatic fibrosis (AHF) and coronary artery disease (CAD). We evaluated the association of AHF with immune activation, systemic inflammation, and adverse outcomes...
7.
Bellissimo M, Canada J, Jordan J, Ladd A, Reding K, Moore T, et al.
JACC CardioOncol
. 2023 Nov;
5(5):641-652.
PMID: 37969655
Background: Cancer treatment increases cardiovascular disease risk, but physical activity (PA) may prevent cardiovascular disease. Objectives: This study examined whether greater PA was associated with better submaximal exercise capacity and...
8.
Suddala S, OConnell N, DAgostino Jr R, Ladd A, Lucas A, Jordan J, et al.
JACC CardioOncol
. 2023 Nov;
5(5):704-706.
PMID: 37969653
No abstract available.
9.
Mehta A, Lee T, Alebna P, Grandhi G, Dixon D, Salloum F, et al.
J Clin Lipidol
. 2023 Nov;
17(6):828-833.
PMID: 37957050
Nonalcoholic fatty liver disease (NAFLD) is associated with atherogenic dyslipidemia and an increased risk of cardiovascular events. Previous studies have suggested an inverse relationship between NAFLD severity and lipoprotein(a) [Lp(a)]...
10.
Bellissimo M, Carbone S, He J, Jordan J, Ambale-Venkatesh B, Lima J, et al.
Prog Cardiovasc Dis
. 2023 Oct;
81:10-16.
PMID: 37852519
Background: Cancer therapies induce cardiac injury and increase cardiovascular disease (CVD) risk. In non-cancer populations, higher diet quality is associated with protection against CVD, but the relationship between diet and...